BridgeBio Pharma Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at J.P. Morgan. I'm joined by my squad, [Laurea] Hall, Priyanka Grover, Malcolm Kuno.
Our next presenting company is BridgeBio. And presenting on behalf of the company, we have CEO, Neil Kumar. Neil?
Thanks so much, Anupam. Thanks to the squad and the entire J.P. Morgan team, including Phil Ross, for having us here again. We've been privileged to present here seven of the eight years we've been around as a company, and we've been through some ups and downs with all of you in this room. And I finally feel like we've arrived at the beginning, really a starting line, if you will.
And what I want to talk about for the next 25 minutes or so is how we intend to come out of that starting block to develop and to create a fully integrated pharmaceutical company that can serve patients with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
